Lenvervimab

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2].

Product Specifications

CAS Number

[2055006-79-4]

Product Name Alternative

GC1102

UNSPSC

12352203

Target

HBV

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/lenvervimab.html

Purity

Solubility

10 mM in DMSO

Smiles

[Lenvervimab]

Molecular Weight

(147.526 kDa)

References & Citations

[1]Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15 (8) :e0236704. |[2]Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18 (13) :3043-3045.e1.